Navigation Links
Omeros Appoints New Vice President of Clinical Development
Date:8/5/2009

SEATTLE, Aug. 5 /PRNewswire/ -- Omeros Corporation today announced the appointment of Stephen R. Murray, M.D., Ph.D. as Vice President of Clinical Development. Dr. Murray will oversee clinical trial strategies and protocols at Omeros, and currently is leading the ongoing clinical studies for Omeros' PharmacoSurgery(TM) product candidates. These include OMS103HP, the Company's lead candidate being evaluated in a Phase 3 clinical program for improved joint function and pain reduction following arthroscopic surgery, OMS302 in a Phase 2 program for use in cataract surgery, and OMS201 in a Phase 1/2 program for use in uroendoscopy.

"Dr. Murray brings a wealth of experience in the pharmaceutical industry, having successfully directed a number of development programs in both large and small pharmaceutical companies," said Gregory A. Demopulos, M.D., Chairman & CEO of Omeros. "Dr. Murray will work closely with our team members to continue building the long-term value of Omeros and our products."

"Omeros is poised to deliver important new treatments to patients through its PharmacoSurgery platform," said Dr. Murray. "In addition, we have several preclinical central nervous system and inflammation programs that have the potential to address significant unmet medical needs. This is an important time for Omeros and I'm excited to play a role here."

Prior to Omeros, Dr. Murray served in various positions, most recently as Chief Medical Officer at Memory Pharmaceuticals, a biopharmaceutical company that developed treatments for central nervous system disorders and was acquired by Hoffman-La Roche Inc. in January 2009. Before that, Dr. Murray held various positions at Pfizer Global Pharmaceuticals, including senior medical director and therapeutic team leader for schizophrenia. Dr. Murray received his M.D. and Ph.D. in molecular and cellular biology from the Medical University of South Carol
'/>"/>

SOURCE Omeros Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
2. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
3. Omeros and BlueCrest Announce $20 Million Debt Facility
4. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
5. Omeros Appoints David A. Mann to its Board of Directors
6. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
7. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
8. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
9. Brookstone Pharmaceuticals Appoints New Corporate Position
10. PDI Appoints Gerald P. Belle as Lead Independent Director
11. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014 An analysis by ... of all Dengue virus strains in Pubmed, has revealed ... to 1944. This conservation and sharing of specific Replikin ... Dengue Blocker-Vaccine™ candidate, as it did for the H5N1 ... of which have been found to be effective (1,2). ...
(Date:8/26/2014)... 26, 2014   Lycera Corp ., a ... medicines to treat autoimmune disease and cancer based ... the appointment of Harinder Singh , Ph.D., ... Dr. Singh will lead the board,s efforts to ... ongoing research programs and pipeline of therapies targeting ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... Switzerland (PRWEB) August 26, 2014 ... for drug discovery and life science research, today ... Meetings will be held in Asia, Europe, ... from global pharmaceutical companies and leading research organizations ... share best practices, case studies, and upcoming challenges ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3
... , NEW YORK , July 27 ... announced the completion of a $5 million round ... Alleghany Corporation (N Y SE: Y), and other investors. ... leading position in the global online patent validation sector by ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) will conduct a conference call ... 2010 at 4:30 p.m. Eastern time ( 1:30 p.m. Pacific ... To participate in the ... 287-9361 (International). In addition, the call will be webcast live and can be ...
... physicists and materials scientists at the University of ... to rapidly grow centimeter-scale membranes of binary nanocrystal ... nanocrystals on a liquid surface. The study ... long-range-ordered BNSL membranes with rigorous control of nanocrystal ...
Cached Biology Technology:Article One Announces Completion of Funding from Alleghany Corporation 2Article One Announces Completion of Funding from Alleghany Corporation 3Penn collaboration leads to simpler method for building varieties of nanocrystal superlattices 2Penn collaboration leads to simpler method for building varieties of nanocrystal superlattices 3
(Date:8/25/2014)... PULLMAN, Wash.Five years ago this month, one of the ... the Washington State University campus, striking some 2,000 people. ... trove of data gathered at the time to gain ... launch the virus,s rapid spread across the university community., ... first cases came in to the university,s Health and ...
(Date:8/25/2014)... Researchers at the University of California, San Diego School of ... certain glioblastomas the primary form of a deadly brain ... not in the DNA sequence of the tumor, but in ... a priority report in the journal Oncotarget . ... by sequencing the DNA of the cancer cell," said Clark ...
(Date:8/25/2014)... family of proteins that promotes virus entry into cells ... HIV and other viruses, University of Missouri researchers have ... new insights into our understanding of not only HIV ... said Shan-Lu Liu, M.D., Ph.D., associate professor in the ... Immunology. , The study was recently published in the ...
Breaking Biology News(10 mins):WSU flu outbreak provides rare study material 2WSU flu outbreak provides rare study material 3Finding keys to glioblastoma therapeutic resistance 2MU researchers discover protein's ability to inhibit HIV release 2MU researchers discover protein's ability to inhibit HIV release 3
... shines a blue light on yeast and mammalian cells in her ... The effect is the result of a light-activated switch from a ... use this novel "on-off switch" to control cell growth or death, ... cells, said Tucker, an assistant research professor in the biology department ...
... The ocean surface is 30 percent more acidic today than it ... 50 years - a rising trend that could both harm coral ... the ocean food web, scientists warn. Despite the seriousness of ... deploy a complete suite of available tools to monitor rising acidification ...
... have found new evidence linking "Snowball Earth" glacial events to ... the National Science Foundation (NSF). Study results appear in ... The controversial Snowball Earth hypothesis posits that, on several occasions, ... thick sheet of ice lasting for millions of years. ...
Cached Biology News:Researchers could use plant's light switch to control cells 2Speed installation of system to monitor vital signs of global ocean, scientists urge 2Speed installation of system to monitor vital signs of global ocean, scientists urge 3Speed installation of system to monitor vital signs of global ocean, scientists urge 4Speed installation of system to monitor vital signs of global ocean, scientists urge 5Speed installation of system to monitor vital signs of global ocean, scientists urge 6Speed installation of system to monitor vital signs of global ocean, scientists urge 7Speed installation of system to monitor vital signs of global ocean, scientists urge 8Animal evolution springs from 'Snowball Earth' 2
...
Phospho-Btk (Tyr223) Antibody...
...
... to Ki67 - Proliferation Marker, prediluted ... related nuclear protein, expressed by proliferating cells ... cycle (G1, S, G2 and M phase). ... Ki67 antibodies are useful in establishing the ...
Biology Products: